Sleep apnoea therapy

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSleep apnoea therapy
Drug Alias NameTASK channel blocker
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsSleep Apnea Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsSleep Apnea Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A